VANI
Vivani Medical, Inc. Common Stock (DE)
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Best Electromedical Stocks 2026 →
VANI Stock Analysis: Buy, Sell, or Hold?
$1.01
+0.03 (+2.70%)
▲
5d:
-5.61%
30d:
-12.17%
90d:
-25.19%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (83%)
Quality Score
38/100
Position
OVERSOLD
30-Day Fair Range
$1.07 – $1.20
Position: OVERSOLD
Forward P/E & Valuation
-2.6x
Next 12M consensus est.
Wall Street Target
$3.83
+279.5% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.80 / $1.16
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: VANI shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When VANI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: VANI is currently trading at $1.01, which is considered oversold relative to its 30-day fair value range of $1.07 to $1.20.
Technical Outlook: Technically, VANI is in a downtrend. Immediate support is located at $0.80, while resistance sits at $1.16.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $3.83 (+279.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, VANI is in a downtrend. Immediate support is located at $0.80, while resistance sits at $1.16.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $3.83 (+279.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.07 -
$1.20
Company Quality Score
38/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
82.6%
Trading Range & Key Levels
30-Day Trading Range
$1.07 -
$1.20
Current vs Trading Range
OVERSOLD
Support Level
$0.80
Resistance Level
$1.16
Current Trend
Downtrend
Technical data as of
Nov 13, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 279.5% below Wall St target ($3.83)
- WARNING: Composite score 38/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-2.59
Wall Street Target
$3.83
(+279.5%)
Share VANI Analysis
Share this live VANI analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (VANI)
Bullish
2 Retail Mentions
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary:
Vivani Medical reported a loss of $7.3 million in Q3, resulting in an earnings loss of 8 cents per share.
Key Retail Themes:
Q3 Earnings
Company Financial Performance
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 6:14 PM ET
Data refreshes hourly during market hours. Next update: 7:14 PM
Data refreshes hourly during market hours. Next update: 7:14 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VANI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$302 | 60 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
STRONG BUY
32 analysts |
$592 | 40 SELL |
|
ONC
BeOne Medicines AG |
STRONG BUY
27 analysts |
$438 | 36 SELL |
|
ASND
Ascendis Pharma AS |
STRONG BUY
21 analysts |
$304 | 39 SELL |
|
KURA
Kura Oncology Inc |
STRONG BUY
16 analysts |
$32 | 63 BUY |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive VANI Research Pages
